• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,009.70 -479.26
( -0.63%)
Global Indices
Nasdaq
50,600.70 294.03
(0.58%)
Dow Jones
7,494.47 27.75
(0.37%)
Hang Seng
64,932.04 -226.15
(-0.35%)
Nikkei 225
10,466.26 22.79
(0.22%)
Forex
USD-INR
95.61 -0.67
(-0.70%)
EUR-INR
110.97 -0.85
(-0.76%)
GBP-INR
128.43 -0.86
(-0.66%)
JPY-INR
0.60 0.00
(-0.79%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
17.34
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
317.33
72.59
EPS(TTM)
Face Value()
Div & Yield %
0.15
10
0
 

GSM Foils standalone net profit rises 83.63% in the March 2026 quarter
Apr 18,2026
Net profit of GSM Foils rose 83.63% to Rs 6.28 crore in the quarter ended March 2026 as against Rs 3.42 crore during the previous quarter ended March 2025. Sales rose 79.11% to Rs 81.69 crore in the quarter ended March 2026 as against Rs 45.61 crore during the previous quarter ended March 2025.

For the full year,net profit rose 105.60% to Rs 19.84 crore in the year ended March 2026 as against Rs 9.65 crore during the previous year ended March 2025. Sales rose 92.94% to Rs 258.15 crore in the year ended March 2026 as against Rs 133.80 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales81.6945.61 79 258.15133.80 93
OPM %11.5312.72 -11.5411.36 -
PBDT8.605.07 70 27.1513.91 95
PBT8.444.99 69 26.6913.63 96
NP6.283.42 84 19.849.65 106